Last reviewed · How we verify
A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)
The purpose of this study is to evaluate the safety and tolerability of pemigatinib in Japanese subjects with advanced malignancies.
Details
| Lead sponsor | Incyte Corporation |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 44 |
| Start date | Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Mar 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Solid Tumors
Interventions
- Pemigatinib
Countries
Japan